oxoglaucine has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZF; Geng, B; Huang, KB; Liang, H; Liu, YC; Shi, YF | 1 |
| Chen, ZF; Jiang, YH; Khan, TM; Li, ZQ; Liang, H; Liu, YC; Qin, JL; Shen, WY; Wang, M; Wei, JH | 1 |
| Chen, ZF; Geng, B; Hong, X; Liang, H; Liu, YC; Peng, Y; Shi, YF | 1 |
3 other study(ies) available for oxoglaucine and Benign Neoplasms
| Article | Year |
|---|---|
Oxoglaucine-lanthanide complexes: synthesis, crystal structure and cytotoxicity.
Topics: Apomorphine; Apoptosis; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Lanthanoid Series Elements; Models, Molecular; Neoplasms; Tumor Cells, Cultured | 2014 |
Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.
Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium | 2015 |
TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apomorphine; Cattle; Cell Cycle; Cell Line; Coordination Complexes; Crystallography, X-Ray; DNA; DNA Topoisomerases, Type I; Drugs, Chinese Herbal; Humans; Models, Molecular; Neoplasms; Topoisomerase I Inhibitors; Transition Elements | 2012 |